The implementation and success of ERT can significantly influence public health policies related to rare diseases. Health policy makers rely on epidemiological data to allocate resources for ERT programs, develop guidelines for diagnosis and treatment, and ensure equitable access to therapy. Additionally, cost-effectiveness analyses of ERT help in making informed decisions about funding and reimbursement.
